3,4-di-substituted cyclobutene-1, 2 - diones as CXC chemokine receptor antagonists

Details for Australian Patent Application No. 2002303084 (hide)

Owner Schering Corporation Pharmacopeia Drug Discovery, Inc.

Inventors Merritt, J., Robert; Pachter, Jonathan; Bond, Richard, W.; Nelson, Kingsley, H., Jr.; Aki, Cynthia, J.,; Ferreira, Johan, A.; Baldwin, John, J.; Rokosz, Laura, L.; Taveras, Arthur, G.; Dwyer, Michael; Kaiser, Bernd; Li, Ge; Chao, Jianping

Agent Griffith Hack

Pub. Number AU-B-2002303084

PCT Number PCT/US02/02888

PCT Pub. Number WO2002/076926

Priority 60/265,951 02.02.01 US

Filing date 1 February 2002

Wipo publication date 8 October 2002

Acceptance publication date 25 May 2006

International Classifications

C07C 225/20 (2006.01) Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

C07C 229/42 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 229/64 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 237/36 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 237/44 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 255/58 (2006.01) Carboxylic acid nitriles

C07C 255/59 (2006.01) Carboxylic acid nitriles

C07C 271/20 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 311/08 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/21 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

C07D 207/08 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/60 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/89 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/38 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 235/06 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 249/18 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 277/28 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 285/08 Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 60/265,951 02.02.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002303084

11 November 2004 Assignment before Grant

  Schering Corporation; Pharmacopeia, Inc. The application has been assigned to Schering Corporation; Pharmacopeia Drug Discovery, Inc.

25 May 2006 Application Accepted

  Published as AU-B-2002303084

21 September 2006 Standard Patent Sealed

20 September 2007 Change of Name(s) of Applicant(s), Section 104

  Pharmacopiea Drug Discovery, Inc.; Schering Corporation The name of the applicant has been changed to Pharmacopiea, Inc.; Schering Corporation

28 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303085-Custom-moldable patellar support , support product for improved patella tracking, and method

2002303083-FIBER-OPTIC CABLE ALIGNMENT SYSTEM